- Home
- PROK vs ASPC Comparison
PROK vs ASPC Comparison
Compare PROK & ASPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PROK
- ASPC
- Stock Information
- Founded
- PROK 2015
- ASPC 2024
- Country
- PROK United States
- ASPC Hong Kong
- Employees
- PROK N/A
- ASPC N/A
- Industry
- PROK Biotechnology: Biological Products (No Diagnostic Substances)
- ASPC
- Sector
- PROK Health Care
- ASPC
- Exchange
- PROK Nasdaq
- ASPC Nasdaq
- Market Cap
- PROK 85.5M
- ASPC 82.6M
- IPO Year
- PROK N/A
- ASPC 2024
- Fundamental
- Price
- PROK $0.58
- ASPC $10.23
- Analyst Decision
- PROK Hold
- ASPC
- Analyst Count
- PROK 3
- ASPC 0
- Target Price
- PROK $3.50
- ASPC N/A
- AVG Volume (30 Days)
- PROK 1.6M
- ASPC 4.0K
- Earning Date
- PROK 08-08-2025
- ASPC 01-01-0001
- Dividend Yield
- PROK N/A
- ASPC N/A
- EPS Growth
- PROK N/A
- ASPC N/A
- EPS
- PROK N/A
- ASPC 0.05
- Revenue
- PROK $306,000.00
- ASPC N/A
- Revenue This Year
- PROK $54.34
- ASPC N/A
- Revenue Next Year
- PROK N/A
- ASPC N/A
- P/E Ratio
- PROK N/A
- ASPC $220.74
- Revenue Growth
- PROK N/A
- ASPC N/A
- 52 Week Low
- PROK $0.46
- ASPC $9.95
- 52 Week High
- PROK $2.59
- ASPC $10.51
- Technical
- Relative Strength Index (RSI)
- PROK 39.22
- ASPC N/A
- Support Level
- PROK $0.54
- ASPC N/A
- Resistance Level
- PROK $0.90
- ASPC N/A
- Average True Range (ATR)
- PROK 0.13
- ASPC 0.00
- MACD
- PROK -0.03
- ASPC 0.00
- Stochastic Oscillator
- PROK 8.06
- ASPC 0.00
About PROK ProKidney Corp.
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's cells isolated from the patient intended for treatment. Its product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.
About ASPC A SPAC III Acquisition Corp. Class A Ordinary Shares
A SPAC III Acquisition Corp is a blank check company.